Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03658772 |
| Title | Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Arrys Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mayo Clinic Cancer Center - Scottsdale | Phoenix | Arizona | 85054 | United States | Details | |
| University of Colorado Denver-Anschutz Medical Campus | Aurora | Colorado | 80045 | United States | Details | |
| Sarah Cannon Research Institute, LLC (SCRI) | Nashville | Tennessee | 37203 | United States | Details | |
| New Experimental Therapeutics of San Antonio-NEXT Oncology | San Antonio | Texas | 78240 | United States | Details |